EnBio Holdings, Inc
Stock Price Chart
2026/10/30 18:57 UpdatedPrice Trend
2026/10/30 18:57 UpdatedPrice & Trading Details
2026/10/30 18:57 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/10/01Dividend History
Updated 2026/10/25| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥9 | 0.0% |
| 2025 | ¥9 | +12.5% |
| 2024 | ¥8 | 0.0% |
| 2023 | ¥8 | 0.0% |
| 2022 | ¥8 | - |
Financial Performance
2026/10/25 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥8,120M | ¥9,576M | ¥10,668M | ¥12,630M |
| Gross Profit | ¥2,764M | ¥2,484M | ¥2,653M | ¥3,688M |
| Operating Income | ¥1,357M | ¥815M | ¥839M | ¥1,619M |
| Pretax Income | ¥1,358M | ¥1,181M | ¥843M | ¥1,094M |
| Net Income | ¥812M | ¥709M | ¥452M | ¥265M |
| EPS | ¥122.27 | ¥88.85 | ¥55.90 | ¥32.73 |
| Operating Margin | 16.72% | 8.51% | 7.86% | 12.82% |
| Balance Sheet | ||||
| Total Assets | ¥17,350M | ¥19,311M | ¥21,195M | ¥22,848M |
| Total Equity | ¥6,788M | ¥8,495M | ¥9,140M | ¥9,246M |
| Total Liabilities | ¥10,562M | ¥10,816M | ¥12,055M | ¥13,602M |
| Cash | ¥2,829M | ¥3,604M | ¥3,293M | ¥4,036M |
| Interest-bearing Debt | ¥8,897M | ¥8,620M | ¥10,097M | ¥10,653M |
| Equity Ratio | 39.12% | 43.99% | 43.12% | 40.47% |
| D/E Ratio | 1.31 | 1.01 | 1.10 | 1.15 |
| Cash Flow | ||||
| Operating CF | ¥1,989M | ¥1,663M | ¥21M | ¥1,167M |
| Investing CF | -¥1,770M | -¥1,584M | -¥1,602M | -¥895M |
| Financing CF | ¥241M | ¥639M | ¥1,274M | ¥464M |
| Free CF | ¥824M | ¥584M | -¥1,446M | ¥114M |
| Efficiency | ||||
| ROE | 11.96% | 8.34% | 4.95% | 2.87% |
| ROA | 4.68% | 3.67% | 2.13% | 1.16% |
Latest IR Information
-
Notice Regarding Sale of Real Estate Held for Sale by Consolidated Subsidiary
The board resolved to sell real estate held for sale by a consolidated subsidiary. Settlement is scheduled for 2027-06-04, the buyer is undisclosed, and the expected revenue contribution is estimated to be at least 10% of the prior fiscal year...
Read more -
Notice of Conclusion of Business Transfer Agreement
A newly established subsidiary will acquire NER Co., Ltd.'s residential and industrial solar power equipment business, O&M, and overseas operations. The transfer price is undisclosed, settlement will be in cash, and the transfer is scheduled to take effect on 2027-02-01....
Read more -
Information about controlling shareholders, etc.
Read more
Latest News (5 items)
Company Information
About
EnBio Holdings, Inc engages in the soil contamination countermeasure business in Japan. The company is involved in the conducting of soil contamination surveys; design and construction of countermeasures; provision of risk consulting; environmental due diligence; import and sale of equipment, materials, and remediation agents; and design, construction, maintenance, and management of water treatment facilities and other construction projects. It also engages in the real estate revitalization business through the purchase, resale, and rental of soil-contaminated land; generation of electricity from solar and biomass sources; water resource development and groundwater contamination treatment projects; ethical consumption promotion projects; and engineering, procurement, construction, operation, and maintenance services for solar power plants and grid-based energy storage facilities. EnBio Holdings, Inc was incorporated in 1999 and is headquartered in Chiyoda, Japan.
